Hepatitis C Virus Clearance after Discontinuation of Pegylated Interferon Alpha-2a Monotherapy in a Child

黃正昌、朱辨弦、吳政億、郭興伯、潘念宗（2011）。Treatment of Chronic Hepatitis B with Surface Antigen Change to Negative and Clinical Analysis of Case Reports。中醫藥研究論叢，14(2)，65-78。https://doi.org/10.6516/TJTCM.201109_14(2).0006
Kemp, W., & Roberts, S. (2011). Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C. Clinical Medicine Insights: Therapeutics, 2011(), 137-150. https://doi.org/10.4137/CMT.S4015
Refaat, B., Ashshi, A. M., Shemi, A. G. E., & Azhar, E. (2015). Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy. Mediators of Inflammation, 2015(), 129-144-112. https://doi.org/10.1155/2015/287640
Chuang, W. L., Chang, W. Y., Lu, S. N., Lin, Z. Y., Chen, S. C., Hsieh, M. Y., Wang, L. Y., Wu, C. C., Chang, S. F., & Chow, T. Y. (1987). Hepatitis D Virus Infection in Patients with Chronic Hepatitis B Virus Infection. The Kaohsiung Journal of Medical Sciences, 3(2), 121-127. https://doi.org/10.6452/KJMS.198702.0121
Liu, C. H. (2015). Optimizing Treatment for Chronic Hepatitis C Patients with Hepatitis C Virus Genotype 1 Infection [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2015.00064